Analyst Consensus ?
ConsensusHold22 ratings
Bullish1150.0%
Neutral836.4%
Bearish313.6%
Booz Allen Hamilton Holding Corporation · BAH · FY2025 Q4 · Calendar Q2 2025
BAH: AI Growth Offsets Civil-Business Restructuring Risk
The supplied analysis supports a mixed view: strong AI, defense and intelligence demand provides evidence for durable growth, while the civil-business decline and restructuring make the broader growth thesis dependent on execution and procurement conditions.
Reported Before market openNYSEIndustrials
$10.03B market cap
80quality score
Earnings scorecard
Reported versus consensus
Reported EPS
—
Consensus $1.59
EPS surprise
—
Reported versus consensus
Reported revenue
—
Consensus $3.03B
Revenue surprise
—
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
-16.5%
Event window
SPY move
-0.7%
Same window
Abnormal move
-15.8%
Stock minus SPY
Volume
6.3×
Versus trailing sessions
Subsequent drift
-7.1%
Up to 20 sessions
BAHSPY benchmark
Ask FN2 about BAH FY2025 Q4
Transcript, numbers and history already loaded
What drove BAH's -16.5% move after FY2025 Q4 earnings?What changed in BAH's guidance and outlook in FY2025 Q4?Give me the bull and bear case for BAH after FY2025 Q4 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The key change was a sharper near-term civil-business reset: management highlighted a roughly 3% revenue headwind this year and a low-double-digit FY2026 decline, alongside targeted restructuring and headcount reductions. The analysis also highlights continued AI, defense and intelligence momentum and a maintained guidance stance.
Guidance delta
Maintained versus the prior quarter; no new numeric guidance range was supplied in the analysis.
Key takeaways
- FY2025 delivered 12% organic revenue growth and 12% adjusted EBITDA growth, exceeding multi-year targets.
- AI revenue exceeded $800 million and grew more than 30% year over year, according to the supplied analysis.
- Management expects a near-term civil-business slowdown, including a low-double-digit FY2026 decline, and is restructuring the segment.
- Defense, intelligence, AI, cloud, quantum, and outcome-based procurement remain central to the FY2026 plan.
Management priorities
- Accelerate AI and advanced technology deployment in defense, intelligence and civil missions.
- Expand outcome-based contracting and deepen GSA/FAS collaborations.
- Invest in quantum, 5G/6G, edge computing and cloud migration capabilities.
- Continue strategic venture investments and partnerships, including further work with Shield AI.
- Hire additional talent in H2 2026 to support growth after civil restructuring.
Follow BAH with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$83.36Current
$65Low
$104.42Average
$174High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 27, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Truist Securities | Buy | Hold | Upgrade | Oct 8, 2026 |
| Jefferies | Hold | Hold | Maintain | Oct 7, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Oct 7, 2026 |
| TD Cowen | Hold | Hold | Maintain | Oct 6, 2026 |
| UBS | Neutral | Neutral | Maintain | Jul 27, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Jul 23, 2026 |
| B of A Securities | Underperform | Underperform | Maintain | Jul 20, 2026 |
| Goldman Sachs | Sell | Sell | Maintain | Jul 14, 2026 |
| Stifel | Buy | Hold | Upgrade | May 26, 2026 |
| JP Morgan | Underweight | Underweight | Maintain | May 26, 2026 |
| William Blair | Outperform | Market Perform | Upgrade | Jul 22, 2025 |
| Barclays | Equal Weight | Equal Weight | Maintain | May 28, 2025 |
| Wells Fargo | Overweight | Overweight | Maintain | May 27, 2025 |
| Raymond James | Outperform | Market Perform | Upgrade | Feb 3, 2025 |
| Morgan Stanley | Overweight | Overweight | Maintain | Feb 2, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Oct 31, 2022 |
| Credit Suisse | Outperform | Outperform | Maintain | Nov 2, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Apr 14, 2020 |
| Vertical Research | Hold | Buy | Downgrade | Jul 9, 2018 |
| Bank of America | Neutral | Neutral | Maintain | Jun 8, 2018 |
| Drexel Hamilton | Hold | Buy | Downgrade | Jun 16, 2017 |
| Stifel Nicolaus | Buy | Buy | Maintain | Nov 26, 2014 |
Named analyst price targets
Upside is calculated against the persisted current price $83.36. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $86 | $82.3 | +3.2% | Oct 26, 2026 |
| National Bank | Analyst unavailable | $95 | $78.32 | +14.0% | Oct 26, 2026 |
| Truist Financial | Tobey Sommer | $85 | $68.69 | +2.0% | Oct 8, 2026 |
| Jefferies | Sheila Kahyaoglu | $75 | $67.24 | -10.0% | Oct 7, 2026 |
| Jefferies | Analyst unavailable | $80 | $75.65 | -4.0% | Sep 1, 2026 |
| UBS | Gavin Parsons | $78 | $72.35 | -6.4% | Jul 27, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $140 | $66.13 | +67.9% | Jul 23, 2026 |
| Goldman Sachs | Noah Poponak | $65 | $64.8 | -22.0% | Jul 14, 2026 |
| Truist Financial | Analyst unavailable | $70 | $63.41 | -16.0% | Jul 10, 2026 |
| BNP Paribas | Analyst unavailable | $80 | $80.26 | -4.0% | May 27, 2026 |
| UBS | Gavin Parsons | $83 | $79 | -0.4% | May 26, 2026 |
| Stifel Nicolaus | Analyst unavailable | $110 | $78.68 | +32.0% | May 26, 2026 |
| Jefferies | Analyst unavailable | $85 | $74.95 | +2.0% | May 11, 2026 |
| UBS | Analyst unavailable | $97 | $92.84 | +16.4% | Jan 27, 2026 |
| D.A. Davidson | Jeff Rulis | $81 | $92.75 | -2.8% | Jan 27, 2026 |
| Stifel Nicolaus | Analyst unavailable | $115 | $102.23 | +38.0% | Jan 26, 2026 |
| Truist Financial | Analyst unavailable | $98 | $102.23 | +17.6% | Jan 23, 2026 |
| Jefferies | Q3 EPS | $95 | $86.85 | +14.0% | Dec 18, 2025 |
| UBS | Analyst unavailable | $93 | $90.22 | +11.6% | Oct 27, 2025 |
| Goldman Sachs | Noah Poponak | $80 | $91.4 | -4.0% | Oct 27, 2025 |
| Stifel Nicolaus | Analyst unavailable | $106 | $91.4 | +27.2% | Oct 24, 2025 |
| Truist Financial | Tobey Sommer | $90 | $91.4 | +8.0% | Oct 24, 2025 |
| UBS | Gavin Parsons | $119 | $109.44 | +42.8% | Jul 28, 2025 |
| Stifel Nicolaus | Jonathan Siegmann | $119 | $109.38 | +42.8% | Jul 28, 2025 |
| UBS | Gavin Parsons | $159 | $148.18 | +90.7% | Dec 2, 2024 |
| Jefferies | Sheila Kahyaoglu | $190 | $182.62 | +127.9% | Nov 4, 2024 |
| Truist Financial | Tobey Sommer | $165 | $156.44 | +97.9% | Sep 5, 2024 |
| Wells Fargo | Matthew Akers | $165 | $139.84 | +97.9% | Jul 29, 2024 |
| Goldman Sachs | Gavin Parsons | $174 | $139.84 | +108.7% | Jul 26, 2024 |
| Truist Financial | Tobey Sommer | $140 | $139.84 | +67.9% | Jul 26, 2024 |
| CFRA | Caydee Blankenship | $160 | $139.84 | +91.9% | Jul 26, 2024 |
| Jefferies | Sheila Kahyaoglu | $185 | $154.6 | +121.9% | May 29, 2024 |
| Wells Fargo | Matthew Akers | $169 | $158.51 | +102.7% | May 28, 2024 |
| Truist Financial | Tobey Sommer | $160 | $158.51 | +91.9% | May 24, 2024 |
| Truist Financial | Tobey Sommer | $145 | $152.36 | +73.9% | May 24, 2024 |
| Jefferies | Sheila Kahyaoglu | $180 | $148.7 | +115.9% | May 14, 2024 |
| Truist Financial | Tobey Sommer | $120 | $120.45 | +44.0% | Jul 31, 2023 |
| Stifel Nicolaus | Bert Subin | $125 | $112.79 | +50.0% | Jul 13, 2023 |
| Morgan Stanley | Matthew Sharpe | $116 | $89.85 | +39.2% | May 26, 2023 |
| Morgan Stanley | Analyst unavailable | $118 | $104.58 | +41.6% | Jan 3, 2023 |
| Morgan Stanley | Analyst unavailable | $110 | $105.32 | +32.0% | Dec 14, 2022 |
| Raymond James | Brian Gesuale | $96 | $84.76 | +15.2% | May 25, 2022 |
| Goldman Sachs | Gavin Parsons | $102 | $87.01 | +22.4% | Apr 19, 2022 |
| Stifel Nicolaus | Bert Subin | $96 | $86.68 | +15.2% | Mar 20, 2022 |
| Bank of America Securities | Ronald Epstein | $90 | $83.49 | +8.0% | Mar 14, 2022 |
| Barclays | David Strauss | $105 | $75.25 | +26.0% | Jan 30, 2022 |
| Morgan Stanley | Matthew Sharpe CFA | $98 | $86.92 | +17.6% | Nov 2, 2021 |
Track every rating change on BAH the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationBooz Allen Hamilton Holding Corporation (BAH) operates as a prominent consulting and technology firm, offering a diverse range of services to governmental bodies, commercial enterprises, and non-profit organizations both domestically and internationally. Their core offerings encompass strategic management and technology advisory, with a focus on areas like business strategy, human resources, and operational efficiency across various sectors. A significant aspect of their work involves advanced analytics.…
Historical context
All BAH earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| FIX Comfort Systems USA, Inc. | FY2026 Q3 · Calendar Q4 2026 | +8.2% | -8.5% | Comfort Systems USA: Strong Growth, Record Backlog, Margin Watchpoints |
| BE Bloom Energy Corporation | FY2026 Q3 · Calendar Q4 2026 | +36.0% | -8.7% | Bloom Energy Raises Outlook as AI Power Demand Drives Expansion |
| SNA Snap-on Incorporated | FY2026 Q3 · Calendar Q4 2026 | -5.9% | -3.4% | Snap-on: C&I strength offsets organic sales pressure in Q3 |
| HON Honeywell International Inc. | FY2026 Q3 · Calendar Q4 2026 | +4.6% | +1.7% | Honeywell Raises 2026 Outlook as Backlog and Forge Support Growth |
| LMT Lockheed Martin Corporation | FY2026 Q3 · Calendar Q4 2026 | +6.0% | +7.0% | Lockheed Martin: backlog and guidance rise, with execution risks |
| NSC Norfolk Southern Corporation | FY2026 Q3 · Calendar Q4 2026 | +4.6% | +3.1% | Norfolk Southern posts strong Q3 as capex outlook rises |
Latest beats and misses
Who reports nextBeat on EPS
- CDNSFY2026 Q3 · October 26, 2026+2.9% EPS+1.8% move
- BAHFY2027 Q2 · October 23, 2026+18.9% EPS-0.3% move
- FCNCAFY2026 Q3 · October 23, 2026+19.9% EPS+8.2% move
- FCNCNFY2026 Q3 · October 23, 2026+19.9% EPS+0.2% move
- FCNCOFY2026 Q3 · October 23, 2026+19.9% EPS+1.0% move
- FCNCPFY2026 Q3 · October 23, 2026+19.9% EPS+1.0% move
Missed on EPS
- INFYFY2027 Q2 · October 23, 2026-4.8% EPS-6.6% move
- BBDFY2026 Q3 · October 22, 2026-7.7% EPS+3.0% move
- SNAFY2026 Q3 · October 22, 2026-5.9% EPS-3.4% move
- SPOTFY2026 Q3 · October 22, 2026-11.6% EPS+11.1% move
- VRSNFY2026 Q3 · October 22, 2026-2.0% EPS-0.9% move
- HBANMFY2026 Q3 · October 22, 2026-5.3% EPS+0.5% move
Get the BAH recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2025-05-09T00:02:11.457598+00:00
- Polygon adjusted daily market bars · 2026-10-27T02:40:43.405589+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-27T02:40:43.402857+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-27. For educational purposes only; not investment advice.